Abbott Laboratories (NYSE:ABT - Free Report) - Investment analysts at William Blair raised their Q3 2025 EPS estimates for Abbott Laboratories in a report issued on Thursday, October 17th. William Blair analyst M. Kaczor now forecasts that the healthcare product maker will post earnings per share
Continue reading...
Continue reading...